1508-76-5|Procyclidine Hydrochloride|1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol;hydrochloride|-范德生物科技公司

Procyclidine Hydrochloride

NMR下载 COA and HPLC MSDS下载
names：
1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol;hydrochloride
CAS号：
1508-76-5
MDL Number：
MF(分子式)： C19H30ClNO MW(分子量)： 323.9
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol;hydrochloride
英文别名	Procyclidine Hydrochloride; Procyclidine HCl; Tricyclamol hydrochloride; (-)-Tricyclamol iodide; C19H29NO.HCl; Procyclidine Hydrochloride; Rosemont Brand of Procyclidine Hydrochloride; Tricyclamol; Wellcome Brand of Procyclidine Hydrochloride;
CAS号	1508-76-5
Inchi	InChI=1S/C19H29NO.ClH/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20;/h1,3-4,9-10,18,21H,2,5-8,11-16H2;1H
InchiKey	ZFSPFXJSEHCTTR-UHFFFAOYSA-N
分子式 Formula	C19H30ClNO
分子量 Molecular Weight	323.9
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Procyclidine Hydrochloride(CAS:1508-76-5):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Procyclidine hydrochloride is a muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in Parkinsonism.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Campbell MJ, Demetriou B, Jones R. Assay of procyclidine hydrochloride,cyclizine hydrochloride and diethylcarbamazine citrate in tablets usingion-responsive electrodes. Analyst. 1980 Jun;105(1251):605-1[1]PubMed PMID:7416480.

[2]Camerman N, Camerman A. The stereochemical basis of anticonvulsant drugaction. 3. The structure of procyclidine hydrochloride. Mol Pharmacol. 1971Jul;7(4):406-12. PubMed PMID: 5113235.

[3] RENZI AA, MILCH LJ. Effectiveness of procyclidine hydrochloride (kemadrin) andcycrimine hydrochloride (pagitane) in the prevention of airsickness. J Aviat Med.1958 Aug;29(8):587-9. PubMed PMID: 13575361.

[4] ZIER A, DOSHAY LJ. Procyclidine hydrochloride (kemadrin) treatment ofparkinsonism; result in 108 patients. Neurology. 1957 Jul;7(7):485-9. PubMedPMID: 13451881.

[5] Schjelderup L, Harbitz O, Groth P, Aasen AJ. Syntheses of(S)-(+)-trihexyphenidyl hydrochloride and (S)-(+)-procyclidine hydrochloride, twoanticholinergics, using (S)-(-)-3-cyclohexyl-3-hydroxy-3-phenylpropanoic acid aschiral synthon. Acta Chem Scand B. 1987 May;41(5):356-61. PubMed PMID: 3673449.

6: Meier V. [Poisoning with procyclidine hydrochloride (Kemadrin)]. SchweizRundsch Med Prax. 1973 Apr 10;62(15):473-5. German. PubMed PMID: 4695200.7: Vas CJ, Exley KA, Parsonage MJ. Activation of the EEG by procyclidinehydrochloride in temporal lobe epilepsy. Epilepsia. 1967 Dec;8(4):241-51. PubMedPMID: 5238716.8: Vas CJ, Exley KA, Parsonage MJ. EEG activation by procyclidine hydrochloridein temporal lobe epilepsy. Electroencephalogr Clin Neurophysiol. 1967Apr;22(4):395. PubMed PMID: 4164765.9: GROSS H, LANGNER E. [Prophylaxis and therapy of a drug-related Parkinsonsyndrome with procyclidine hydrochloride (Kemadrin)]. Wien Klin Wochenschr. 1962Aug 31;7

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开